The patients fulfilling the diagnostic criteria were selected for
the study and interviewed thoroughly along with their family
members and/or relative to obtain detailed information about
the patient as well as the disease and collected in different
data.
The total duration of treatment was fixed for six weeks with
the regular weekly follow-ups. The patients registered for
clinical study were advised, not to take any other drug during
the trial period both internally and externally